VOLUME 64   2003   SUPPLEMENT 13

ARTICLES

4 Introduction: Recent Developments in Achieving Depression Remission. Alan F. Schatzberg
[PDF]

5 Interactions of Antidepressants With Neurotransmitter Transporters and Receptors and Their Clinical Relevance. Elliott Richelson
[Abstract] [PDF]

13 Differences in Mechanism of Action Between Current and Future Antidepressants. Stephen M. Stahl and Meghan M. Grady
[Abstract] [PDF]

18 Evaluating Antidepressant Therapies: Remission as the Optimal Outcome. Michael E. Thase
[Abstract] [PDF]

26 The Role of the Serotonergic and Noradrenergic Neurotransmitter Systems in the Treatment of Psychological and Physical Symptoms of Depression. Maurizio Fava
[Abstract] [PDF]

30 Efficacy and Tolerability of Duloxetine, a Novel Dual Reuptake Inhibitor, in the Treatment of Major Depressive Disorder. Alan F. Schatzberg
[Abstract] [PDF]

CME Section

3 Faculty and Disclosures.
[PDF]

38 Instructions and Posttest.
[PDF]

40 Registration Form and Evaluation.
[PDF]